Cargando…
SARS-COV-2 INFECTION WITH RITUXIMAB THERAPY
Autores principales: | AUGENSTEIN, CHERYL, THANUSHI WYNN, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548789/ http://dx.doi.org/10.1016/j.chest.2022.08.368 |
Ejemplares similares
-
SARS-COV-2 INFECTION AND HEMOFILTRATION-TARGETING VIREMIA
por: MEECE, LYDIA, et al.
Publicado: (2022) -
PLEURAL EFFUSIONS DUE TO SARS-COV-2 INFECTION
por: Ayala, Alvaro, et al.
Publicado: (2020) -
MULTISYSTEM INFLAMMATORY SYNDROME IN AN ADULT POST-SARS-COV-2 INFECTION
por: CHUG, LUIS, et al.
Publicado: (2021) -
RELAPSE AND REMITTING COVID-19 INFECTIONS IN AN IMMUNOSUPPRESSED PATIENT ON CHRONIC RITUXIMAB INFUSIONS
por: GREWAL, SAHIB, et al.
Publicado: (2021) -
SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)